baber/WOPTO huggingface dataset:
Patent NZ-584412-A (NZ)
Title: Screen for a door or window that is wider than it is tall
Inventor: ROBERTS ANTHONY GERARD
IPC: E06B3/32
Filed: 2010-04-01
Abstract: A screen apparatus includes an elongate overhead frame 12 which defines a lengthwise overhead travel path for the screen, and a transverse fixed side frame 20 that is fixedly mounted adjacent its upper end to the overhead frame and which defines a side travel path extending longitudinally up the fixed side frame, that is continuous with the overhead travel path and that has a travel path entrance toward the bottom end. A displaceable side frame 28 that extends parallel to the fixed side frame is displaceable toward and away from the fixed side frame to respectively open and close the pleated screen across the screen aperture. An elongated articulate bottom frame 32 has one end 34 that is attached toward the bottom end of the displaceable side frame so that the articulated bottom frame is displaced when the screen is moved between the closed and open positions. The bottom frame is longer than the length Y of the side travel path so that it enters the side travel path through the travel path entrance, travels up the side travel path and through at least part of the overhead travel path when the screen is opened. This allows the screen to extend across an opening that is considerably wider X than it is high Y.
Patent NZ-590193-A (NZ)
Title: Tilt slab concrete wall with elongate structural sheet metal members in vertical and transverse directions connected to sheet metal decking sheets and with edge channels adapted to nest adjacent wall panels
Inventor: KRALIC JOHN FRANK
IPC: E04B5/40
Filed: 2009-06-12
Abstract: 590193 Disclosed is a composite building panel when used in tilt up wall construction. The panel comprises a deck formed of one or more decking members, a settable cementitious or concrete material cast on the deck, and one or more elongate strengthening reinforcing structural elements embedded in the settable material, with each element being connected to the one or more decking members. The panel is tilted up to an in use configuration where the panel is at least part of a wall and the deck of the composite panel is in a generally vertical orientation, wherein the one or more strengthening elements contribute to the strength and stiffness of the panel both in tilting up of the panel and in place as a wall. The deck comprises two or more adjacent decking members connected together at one or more respective joints wherein each of the one or more strengthening elements is connected at or adjacent to the one or more respective joints.
Patent NZ-591424-A (NZ)
Title: Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof
Inventor: FELEKI ATTILA
IPC: A61K33/06
Filed: 2009-07-28
Abstract: Disclosed herein is a composition containing: a) clay material with a negative surface charge, preferably a zeolite, in particular clinoptilolite; b) magnesium ions and calcium ions both either incorporated within the clay material and/or added separately; c) water and/or non-aqueous solvent; d) substantially non-cationic carrier; i) the mean particle size of the clay material is at least 5 nm, preferably between 5nm and 100µm; and ii) the total molar amount of magnesium ions is higher than the total molar amount of calcium ions, particularly higher than 1.2X. Also disclosed is the use of the composition as defined above in the manufacture of a medicament /medical device for the prophylaxis and treatment of skin diseases, skin conditions or mucosal diseases where the formation and/or recovery of epidermal/mucosal barrier function has beneficial effect.
Patent NZ-599511-A (NZ)
Title: Recombinant human cc10 protein for treatment of influenza
Inventor: PILON APRILE L
IPC: A61K45/00
Filed: 2010-10-13
Abstract: Disclosed is the use of Human CC10 or rhCC10 (uteroglobin) in the manufacture of a medicament for the therapeutic and/or prophylactic treatment of influenza virus infection by reducing the titre of influenza virus in the lung tissue of a patient.
Patent NZ-601686-A (NZ)
Title: System and method for printer emulation
Inventor: GRIBEL STAFFAN
IPC: G06F3/12
Filed: 2010-02-10
Abstract: Disclosed is a system for accurately emulating a printer on a computing device that is not connected to the printer. The computing device is provided with firmware and programming code that interfaces with the firmware for a customised printing operation. The system is comprised of at least one application programming interface, firmware and programming code. The application programming interface is provided with the printer, or is provided with the computing device and the printer. The firmware is provided with the printer and the computing device and is operable on each of the computing device and the printer as a function of the at least one application programming interface. The programming code runs on the computing device and interfaces with the firmware provided with the computing device to cause the computing device to emulate the printer running the programming code.
Patent NZ-603456-A (NZ)
Title: 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
Inventor: AMENDT CHRISTIANE
IPC: A61K31/4375
Filed: 2011-05-31
Abstract: 603456 Disclosed are [1,8]naphthyridine derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases plays a role, particularly to inhibitors of TGF-beta receptor kinases, and to the use of such compounds for the treatment of kinase-induced diseases, in particular for the treatment of tumours. Examples of compounds of formula (I) include: 2-(5-Chloro-2-fluorophenyl)-4-(1H-pyrrolo[2,3-c]pyridin-3-yl)-[1,8]naphthyridine formate; 2-(5-Chloro-2-fluorophenyl)-4- isoquinolin-5-yl-[1,8]naphthyridine and 2-(6-Methylpyridin-2-yl)-4-[2,6]naphthyridin-1-yl-[1,8]naphthyridine. Also disclosed are processes for preparing a compound of formula (I), compositions comprising compounds of formula (I) and the use of compounds of formula (I) in the manufacture of a medicament for treating cancer, carcinomas, tumours and hyperproliferative disorders.
Patent NZ-620448-A (NZ)
Title: Load bearing structure
Inventor: SMOLENAERS PETER
IPC: B65D19/38
Filed: 2012-08-07
Abstract: Disclosed is a metal pallet for loading or stacking cargo upon it designed to minimise its weight, reduce corrosion and allow the use of RFID chips. The pallet includes a deck for carrying cargo; and a frame about a perimeter of the pallet, the frame being formed of horizontally extending tubular portions. One or more elements support the frame above a support surface to overlie one or more openings for receiving the tines of a lifting device or forklift. The tubular portions include lengthwise corrugations and are inwardly directed such that the tubular portions outwardly present aligned planar portions without intermediate projections to suit mating with other components. Each of the tubular portions substantially consists of formed sheet material. Two edges of the sheet material of each of the tubular portions each include a respective return fold; and each fold of each respective tubular portion is energetically bonded using filler material having a melting point of less than about 1150°C to the other fold of the respective tubular portion to define a seam.
Patent NZ-627242-A (NZ)
Title: Transdermal hormone delivery
Inventor: ARNOLD CHARLES G
IPC: A61K31/565
Filed: 2013-01-25
Abstract: Disclosed is a composition for transdermal delivery of a progestin for effecting contraception in a woman, said composition being a polymeric PSA matrix comprising a PSA and an effective amount of desogestrel, wherein the composition does not comprise a skin penetration enhancer. Also disclosed is the use of a progestin in the manufacture of a transdermal delivery composition for effecting contraception in a woman, said composition being a polymeric PSA matrix comprising a PSA and an effective amount of desogestrel, wherein the composition does not comprise a skin penetration enhancer.
Patent NZ-701505-A (NZ)
Title: Interchangeable mask assembly
Inventor: KWOK PHILIP RODNEY
IPC: A61M16/06
Filed: 2006-10-24
Abstract: A mask assembly (600) for a user comprising: a frame (605); a cushion component (615) provided to the frame and defining a breathing cavity configured to accommodate at least a portion of the user’s nose in use, the cushion component including a face contacting seal portion adapted to sealingly engage with at least a portion of the user’s nose in use, the cushion component having an aperture to communicate pressurized gas from the breathing chamber to the user’s airways in use and a main wall portion, opposite from the aperture, extending upwardly away from the frame; and a chin strap assembly (620) including an extension member (625) provided to each side of the frame and a chin strap (630) having a main chin support portion and straps coupled to the extension members.
Patent NZ-702494-A (NZ)
Title: Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
Inventor: BRUCKNER SIMONE
IPC: A61K39/395
Filed: 2011-03-01
Abstract: Disclosed is a monoclonal antibody that binds to human tissue factor pathway inhibitor, wherein the antibody comprises: a) a heavy chain comprising the amino acid sequence shown in SEQ ID NO: 1 having one or more amino acid substitutions selected from the group Q1E, R30S, S31P, S31V, G33A, G33K, G33P, M34I, M34K, S35L, S35D, S50A, I51D, I51E, R52S, S54F, S54D, S55A, S55G, S55R, S56G, K99V, K99L and F104Y and/or one or more amino acid deletions at positions I51, S56 and S57; and b) a light chain comprising the amino acid sequence shown in SEQ ID NO: 2 having one or more amino acid substitutions selected from the group D1S, I2Y, A13S, S21T, N26A R28P, N29K, A32N, H33Y, Y48F, Y49R, N51S, N51V, N52G, P54L, G56D, E80M, S89A, D91L, D91R, D91W, D91K, D92S, D92T, G93S, V94T, P95V, P95A, V96G, V96M and V96W, wherein said antibody binds to human tissue factor pathway inhibitor with a greater affinity than an antibody 2A8, provided that said antibody does not comprise the specific sequences as specifically defined herein.
Patent NZ-706285-A (NZ)
Title: Improved retractable bollard
Inventor: ROBERT CHARLES BROADHURST
IPC: E01F9/646
Filed: 2013-09-27
Abstract: A retractable bollard apparatus 100 comprising an embedded outer housing having an open end and a closed end, a ram 201 slideably mounted within the outer housing, means for adjusting the axial position of the ram between a fully retracted and fully extended position 40, and means for applying a voltage between the ram 201 and the outer housing. The ram 201 and the outer housing each comprise electrical connectors positioned on the ram and outer housing such that, when the ram is in the fully retracted and/or the fully extended position, the electrical connectors on the ram and outer housing are electrically connected such that a detectable change in the electrical characteristics of the ram occurs to indicate that the ram is in the fully retracted and/or full extended position.
Patent NZ-720197-A (NZ)
Title: Means for connecting a wheelchair backrest
Inventor: SCARLETT ROYDON MARK
IPC: A61G5/12
Filed: 2016-05-16
Abstract: The invention relates to means for releasably connecting a wheelchair backrest to a wheelchair frame. This is desirable to facilitate collapse of the wheelchair for transport or storage. In the preferred embodiment, there is a wheelchair having a support frame, a backrest 16 and connector comprising a saddle 1, a bracket 15 and a clamp 17. As shown in Figure 1, 2, 3, 7 and 8 the saddle has a slot 3 with top and front openings and a locking lever 7. Two pins 12a and 12b are received in the slot so they extend through the front opening, and the lever 7 is able to move to divide the slot into top and bottom zones so that a lower one of the pins is prevented from being withdrawn from the slot via the top opening by the lever. The lever can then be moved to unblock the lower pin and allow the slot 3 and the pins 12a and 12b to be dissociated.
Patent NZ-721147-A (NZ)
Title: Bispecific antigen binding molecules
Inventor: KLEIN CHRISTIAN
IPC: C07K16/30
Filed: 2012-08-21
Abstract: Discloses bispecific antigen binding molecules comprising two Fab fragments specific to a first antigen and a second Fab fragment specific to a second antigen fused to a first Fc domain subunit. One of the Fab fragments is a crossover fab fragment with a VH-CL/VLCH1 arrangment. The bispecific antigen binding molecule does not comprise a single chain Fab fragment.
Patent NZ-721984-A (NZ)
Title: Immunoglobulin-like molecules directed against fibronectin-eda
Inventor: ARSLAN FATIH
IPC: C07K16/18
Filed: 2014-12-12
Abstract: The present invention is concerned with immunoglobulin (Ig)-like molecules or fragments thereof for use in treatment, or prevention of progression of adverse cardiac remodelling and conditions resulting from or relating to myocardial infarction and pressure-overload, such as heart failure, aneurysm formation and remote myocardial fibrosis and for use in improving angiogenesis, preferably after ischemic injury. The invention also provides nucleic acid molecules encoding said Ig-like molecules, vectors comprising same, and host cells comprising same.
Patent NZ-737933-A (NZ)
Title: Morse taper protective sleeve
Inventor: TERMANINI ZAFER
IPC: A61F2/30
Filed: 2016-06-06
Abstract: A removable orthopedic protective sleeve adapted to be applied over the male Morse taper of modular orthopedic implants thereby preventing contamination of the taper contact surface from blood, body fluid or tissue particles responsible for electrochemical corrosion and fretting at the level of Morse taper. Said sleeve having a conical tube shape and a rim at is upper narrow end. A plurality of vertical grooves situated on the outer surface of the protective sleeve will split open as the female Morse taper is slidingly flushed downward and seated over the male taper. The split sleeve is then removed after the male and female tapers are assembled in-situ.
Patent NZ-760696-A (NZ)
Title: Metering system for solid particulate
Inventor: MONTAG ROGER A
IPC: B01F23/30
Filed: 2015-01-20
Abstract: A particulate metering system is provided. Particulate metering systems use varied approaches to control the rate at which particulate is metered and/or blended with other particulate types. Particulate metering is complicated by the desire to simultaneously meter at separate discharge points varying rates and blends of different particulate. In such instances where the particulate is fertilizer, there’s a significant interest in controlling the blend and application rate of two or more fertilizers, and specifically controlling a variation in the blend and application rate of two or more fertilizers at separate discharge points, such as at separate rows in a field. The system includes a plurality of flow paths, each flow path having an inlet in communication with an intake and an outlet in communication with a discharge. The plurality of flow paths receives a first input and each of the plurality of flow paths receives a plurality of particulate inputs each having a separate origin at a particulate bin. A mixing area within each of the plurality of flow paths comprising a confluence of the first gas input and two or more of the plurality of particulate inputs. One or more metering controls in operable communication with the first gas input and the plurality of particulate inputs for controlling a blend of the plurality of particulate inputs at the confluence, wherein the one or more metering controls are disposed outside the mixing area. Fig 1A
Patent NZ-761665-A (NZ)
Title: Connector for a fluid handling system
Inventor: CAMPAU DANIEL N
IPC: A44B11/26
Filed: 2018-07-03
Abstract: The specification discloses a marine fluid connection system including a fitting and a connector. The fitting is cylindrical and incudes a radially extending flange. The connector includes a cylindrical body, a plurality of levers on the body, and a locking ring on the body. The levers are movable between a latched position, in which the levers are closed on the flange to lock the connector on the fitting, and an unlatched position, in which the levers are open so that the connector may be removed from the fitting. The locking ring is axially movable with respect to the body to move the latches between their latched and unlatched positions. The body, levers, and the locking ring are separate and/or or independent of one another. Therefore each component may be fabricated of a material selected and optimized for the function of that component.
Patent NZ-763453-A (NZ)
Title: Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
Inventor: DOKOU ELENI
IPC: A61K45/06
Filed: 2015-04-14
Abstract: The present invention features compositions comprising a plurality of therapeutic agents wherein the presence of one therapeutic agent enhances the properties of at least one other therapeutic agent. In one embodiment, the therapeutic agents are cystic fibrosis transmembrane conductance regulators (CFTR) such as a CFTR corrector or CFTR potentiator for the treatment of CFTR mediated diseases such as cystic fibrosis. Methods and kits thereof are also disclosed. More specifically the invention provides a spray dried dispersion comprising (R)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1 / Tezacaftor) and N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 2 / Ivacaftor), wherein the spray dried dispersion optionally further comprises a polymer and/or one or more additional therapeutic agents, and wherein the ratio of Compound 1 to Compound 2 is from 1:1 to 1:3 by weight.
Patent PT-103895-A (PT)
Title: Tintas com incorporação de partículas de cortiça para melhor comportamento térmico e acústico
Inventor: GIL LUIS MANUEL DA COSTA CABRA
IPC: C09D5/02
Filed: 2007-11-28
Abstract: O PRESENTE INVENTO REFERE-SE A NOVAS TINTAS COM INCORPORAÇÃO DE PARTÍCULAS DE CORTIÇA DE MODO A OBTER-SE UM MELHOR COMPORTAMENTO DESTAS A NÍVEL DO ISOLAMENTO TÉRMICO E DA ABSORÇÃO ACÚSTICA (REVERBERAÇÃO) . ESTAS TINTAS SÃO OBTIDAS POR MISTURA DE TINTAS CORRENTES PARA INTERIORES E EXTERIORES DE EDIFÍCIOS COM PARTÍCULAS DE CORTIÇA COM DIFERENTES GRANULOMETRIAS E EM DIFERENTES PROPORÇÕES. AS TINTAS COM CORTIÇA APRESENTAM UMA MENOR CONDUTIVIDADE TÉRMICA E UMA MAIOR ABSORÇÃO ACÚSTICA (DIMINUIÇÃO DO ECO), CONDUZINDO A UM MELHOR COMPORTAMENTO TÉRMICO E ACÚSTICO QUANDO COMPARADAS COM AS TINTAS CORRENTES, CONTRIBUINDO PARA UMA MELHOR HABITABILIDADE.
Patent PT-104329-A (PT)
Title: Painel de cofragem para pilares e muros
Inventor: FELIX JOSE LUIS UBINANA
IPC: E04G11/00
Filed: 2009-01-12
Abstract: O PRESENTE INVENTO DIZ RESPEITO A UM PAINEL DE COFRAGEM PARA PILARES E MUROS, CARACTERIZADO POR A FACE DE COFRAGEM E NO MÍNIMO OS DOIS LADOS DE MAIOR COMPRIMENTO, TAIS COMO O LADO (2), SEREM CONSTITUÍDOS POR ENFORMAÇÃO MECÂNICA DE UM ÚNICO ELEMENTO EM CHAPA (1), APRESENTANDO OS REFERIDOS LADOS UMA PRIMEIRA QUINAGEM PERPENDICULAR AO PAINEL E UMA SEGUNDA QUINAGEM CONSTITUTIVA DE UMA ABA (10) DIRIGIDA PARA O INTERIOR DO PAINEL.
Patent PT-105032-A (PT)
Title: Sistema e método para a eliminação de toxinas através de um processo de electrólise
Inventor: CARDOSO PAULO TELMO DIAS DO SOCORRO TEIXEIRA
IPC: A61N1/00
Filed: 2010-03-29
Abstract: A PRESENTE INVENÇÃO ESTÁ RELACIONADA COM UM CONJUNTO DE DISPOSITIVOS E RESPECTIVO MÉTODO PARA A ELIMINAÇÃO DE TOXINAS ATRAVÉS DE UM PROCESSO DE ELECTRÓLISE, O QUAL COMPREENDE UMA ESTRUTURA (1) CONTENDO UM SISTEMA ELECTRÓNICO DE CONTROLO DO PROCESSO, LIGADO A UM CONJUNTO DE ELÉCTRODOS (2) E (3) E RESPECTIVO SUPORTE (4) E PELO MENOS UM TIPO DE RECIPIENTE (5), DE ACORDO COM O TRATAMENTO QUE SE PRETENDA EFECTUAR. A INVENÇÃO AGORA PROPOSTA É PARTICULARMENTE ÚTIL NA ELIMINAÇÃO DE TOXINAS ACUMULADAS EM VÁRIAS PARTES DO CORPO HUMANO, ATRAVÉS DA ESTIMULAÇÃO ELÉCTRICA DE CÉLULAS E CENTROS NERVOSOS.
Patent PT-105631-A (PT)
Title: Composição de ligantes de partículas finas usada na construção civil compreendendo oligómeros ramificados de polioxialquilenoglicol
Inventor: NUNES ANGELA MARIA JESUS DE SEQUEIRA SERRA
IPC: C04B24/24
Filed: 2011-04-18
Abstract: A PRESENTE INVENÇÃO DIZ RESPEITO A COMPOSIÇÕES DE LIGANTES DE PARTÍCULAS FINAS USADAS NA CONSTRUÇÃO CIVIL SOB A FORMA DE MISTURAS DE PÓS SECOS OU JÁ PRÉ-HIDRATADOS, QUE COMPREENDE, COMO AGENTE REDUTOR DAS POEIRAS EMITIDAS PELAS FORMULAÇÕES DE LIGANTES EM ESTADO SECO OU COMO AGENTE REDUTOR DA SEGREGAÇÃO DE INERTES NAS FORMULAÇÕES DE LIGAN¬TES PRÉ-HIDRATADOS, OLIGÓMEROS RAMIFICADOS DE POLIOXIAL¬QUILENO¬GLICOL COM ESTRUTURA EM ESTRELA, PESO MOLECULAR MÉDIO ENTRE 300 E 6000 G/MOL E GRAU DE RAMIFICAÇÃO ENTRE 3 E 8. É AINDA ANALISADO O EFEITO DA ADIÇÃO DE OLIGÓMEROS RAMIFICADOS DE POLIOXIAL-QUILENOGLICOL EM PROPRIEDADES FUNDAMENTAIS PARA O DESEM-PENHO DOS LIGANTES DURANTE E APÓS A APLICAÇÃO COMO SÃO O TEMPO DE PRESA, A EXPANSIBILIDADE, A DEFORMABILIDADE, A RESISTÊNCIA MECÂNICA E A ESTABILIDADE DIMENSIONAL.
Patent PT-107295-A (PT)
Title: Travessa de suporte do painel de intrumentos reforçada por molas à compressão e com função de redução de volume para transporte
Inventor: SOARES TIAGO JOSÉ MARTINHO
IPC: B62D21/15
Filed: 2013-11-14
Abstract: O PRESENTE INVENTO DIZ RESPEITO A UMA TRAVESSA DE SUPORTE DO PAINEL DE INSTRUMENTOS REFORÇADA POR MOLAS À COMPRESSÃO E COM FUNÇÃO DE REDUÇÃO DE VOLUME PARA TRANSPORTE, APLICADA A VEÍCULOS MOTORIZADOS E DESTINADA A GARANTIR A RIGIDEZ DO PAINEL DE INSTRUMENTOS, QUE COMPREENDE UMA ESTRUTURA PRINCIPAL (1.1) COMPOSTA POR DIVERSOS TUBOS (2, 3, 4) COM DIFERENTES DIMENSÕES, POR OS TUBOS (2, 3, 4) ESTAREM LIGADOS ENTRE SI POR VIA DE ELEMENTOS DE FIXAÇÃO MECÂNICOS (14, 15, 20, 21), POR OS TUBOS DE MAIOR DIMENSÃO (2) E INTERMÉDIO (3) APRESENTAREM UMA VARIAÇÃO DE SECÇÃO NUMA DAS EXTREMIDADES (2.1, 3.1), POR TER ALOJADOS ELEMENTOS MOLA (5, 6) NAS EXTREMIDADES DOS TUBOS DE MAIOR DIÂMETRO (2) E NO TUBO INTERMÉDIO (3), POR OS TUBOS DE MENOR DIMENSÃO E INTERMÉDIO (3, 4) APRESENTAREM GOLAS NUMA DAS EXTREMIDADES DE GEOMETRIA VARIÁVEL (16, 17) E POR OS MESMOS TUBOS (3, 4) TEREM A CAPACIDADE DE SER RECOLHIDOS PARA O INTERIOR DO TUBO DE MAIOR DIÂMETRO (2), POR VIA DE MOVIMENTOS ROTACIONAIS E LONGITUDINAIS, RESULTANDO NUMA REDUÇÃO DE VOLUME LATERAL EM SITUAÇÕES DE TRANSPORTE.
Patent PT-110318-A (PT)
Title: Desidratador para hortofrutícolas e método de funcionamento
Inventor: JOÃO NUNO PINTO MIRANDA GARCIA
IPC: A23L3/54
Filed: 2017-09-29
Abstract: A INVENÇÃO DESCRITA NESTE DOCUMENTO REFERE-SE A EQUIPAMENTO DESTINADO A DESIDRATAR HORTOFRUTÍCOLAS CONSTITUÍDO POR: PAINEL SOLAR TÉRMICO (2), PAINEL SOLAR FOTOVOLTAICO (1), CÂMARA DE DESIDRATAÇÃO (3), RESISTÊNCIA ELÉTRICA (7), VENTILADORES DE AR (6) PARA FORÇAR A CIRCULAÇÃO DO AR NO INTERIOR DA CÂMARA DE DESIDRATAÇÃO (3), VÁLVULA DE ADMISSÃO (4) E VÁLVULA DE EXAUSTÃO (5) DO AR, SONDAS DE TEMPERATURA E HUMIDADE E O RESPETIVO CONTROLADOR (8) QUE ASSEGURA QUE O SISTEMA FUNCIONE SEGUNDO AS CONDIÇÕES PREVIAMENTE DETERMINADAS, COBERTURA (9) E BATERIA (10).
Patent RU-94010347-A (RU)
Inventor: POKROVSKIJ A V
IPC: A61B17/00
Filed: 1994-03-23
Abstract: FIELD: medicine; vascular surgery. SUBSTANCE: method involves sequential isolation of the main artery above the occlusion site in the non-affected segment and the beginning of the head vein at the wrist joint on the lateral surface, then the head vein part is mobilized in the prospective proximal anastomosis area and divided. The proximal end of the vein is ligated, and the distal part is moved towards the isolated artery for end-to-side anastomosis. The valves are destroyed in the main trunk and beginning of the vein, and large branches of the vein are ligated. EFFECT: higher treatment efficacy.